Fedha

Hisa unazofuatilia
IPSEY:OTCMKTS
Ipsen ADR Rep 1/4 Ord Shs
US$ 40.15
+0.65%
(+0.26) Siku 1
8 Okt, 16:00:00 GMT -4  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya IPSEY...
Fungua
US$ 39.12
Juu
US$ 40.15
Chini
US$ 39.12
Mtaji wa soko
12.55B
Wastani wa kiasi cha mauzo
842.00
Kiasi cha mauzo ya hisa
elfu 16.34
Juu kwa wiki 52
US$ 51.10
Chini kwa wiki 52
US$ 32.68
Beta
0.41
Hisa za wawekezaji
335.26M
Idadi ya wafanyakazi
elfu 6
Fungua
US$ 39.12
Juu
US$ 40.15
Chini
US$ 39.12
Mtaji wa soko
12.55B
Wastani wa kiasi cha mauzo
842.00
Kiasi cha mauzo ya hisa
elfu 16.34
Juu kwa wiki 52
US$ 51.10
Chini kwa wiki 52
US$ 32.68
Beta
0.41
Hisa za wawekezaji
335.26M
Idadi ya wafanyakazi
elfu 6
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employees worldwide. Ipsen's medicines are registered in 88 countries with direct commercial presence in over 30 countries. Ipsen has 4 global R&D hubs and 3 pharmaceutical development centers around the world. Ipsen has been a family-owned business for the past 90 years and is publicly traded on the Euronext Paris as part of the SBF 120 index. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors. Wikipedia
Kuhusu Ipsen ADR Rep 1/4 Ord Shs
Afisa Mkuu Mtendaji (CEO)David Loew
Wafanyakazielfu 5.54
Lilianzishwa1929
Makao makuu-
Sekta-
Tovutiipsen.com
Ripoti za awaliThamani zote katika EUR
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika EUR
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
996.05M
996.05M
1.15B
1.15B
Gharama ya bidhaa zilizouzwa
212.90M
212.90M
217.60M
217.60M
Gharama ya mapato
212.90M
212.90M
217.60M
217.60M
Gharama za utafiti na maendeleo
194.55M
194.55M
201.25M
201.25M
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
278.60M
278.60M
304.15M
304.15M
Gharama ya uendeshaji
523.20M
523.20M
604.50M
604.50M
Jumla ya gharama za uendeshaji
736.10M
736.10M
822.10M
822.10M
Mapato ya uendeshaji
259.95M
259.95M
327.50M
327.50M
Mapato mengine yasiyo ya uendeshaji
-7.35M
-7.35M
-6.50M
-6.50M
EBT ikijumuisha vipengee visivyo vya kawaida
76.55M
76.55M
273.85M
273.85M
EBT bila kujumuisha vipengee visivyo vya kawaida
248.45M
248.45M
316.50M
316.50M
Gharama ya kodi ya mapato
22.05M
22.05M
72.55M
72.55M
Kiwango cha kodi kinachotumika
28.80%
28.80%
26.49%
26.49%
Gharama nyingine za uendeshaji
50.05M
50.05M
99.10M
99.10M
Mapato halisi
54.75M
54.75M
201.55M
201.55M
Kiwango cha faida halisi
5.50%
5.50%
17.53%
17.53%
Mapato kwa kila hisa
-
-
-
-
Mapato ya riba na uwekezaji
8.25M
8.25M
8.80M
8.80M
Gharama ya riba
-10.20M
-10.20M
-10.45M
-10.45M
Jumla ya gharama halisi za riba
-1.95M
-1.95M
-1.65M
-1.65M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
331.25M
331.25M
401.65M
401.65M
Faida au hasara kutokana na uuzaji wa vipengee
9.75M
9.75M
elfu 900.00
elfu 900.00
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google